Skip to content
Screener

Heron Therapeutics HRTX Q2 2026 earnings

Reported August 10, 2026 · Before market open

Revenue$37.7MMiss by $4.5M
EPS-$0.03Miss by $0.02
Revenue estimate$42.2M
EPS estimate-$0.01

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$37.5M
EPS estimate-$0.03

FAQ

When did Heron Therapeutics report Q2 2026 earnings?
Heron Therapeutics (HRTX) reported Q2 2026 earnings on August 10, 2026 before market open.
What were Heron Therapeutics's Q2 2026 revenue and EPS?
Heron Therapeutics reported revenue of $37.7M and eps of $-0.03 for Q2 2026.
Did Heron Therapeutics beat estimates in Q2 2026?
Revenue missed the consensus estimate of $42.2M by $4.5M. EPS missed the consensus estimate of $-0.01 by $0.02.
How did Heron Therapeutics's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.3% from $37.2M a year earlier and eps declined 50.0% from $-0.02.
Where can I find Heron Therapeutics's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-341300) and the 10-Q periodic report (0001193125-26-341301) directly on SEC EDGAR. The filing index links above go to sec.gov.